Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Update

Fresenius SE & Co. (OTCMKTS:FSNUY) was the target of a significant drop in short interest in December. As of December 31st, there was short interest totaling 11,203 shares, a drop of 88.7% from the December 15th total of 98,734 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 48,099 shares, the days-to-cover ratio is currently 0.2 days. Based on an average daily trading volume, of 48,099 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.0% of the company’s stock are sold short.

Fresenius SE & Co. Trading Up 3.5%

Shares of OTCMKTS:FSNUY traded up $0.50 during mid-day trading on Monday, hitting $14.82. The company had a trading volume of 24,582 shares, compared to its average volume of 50,529. Fresenius SE & Co. has a one year low of $8.80 and a one year high of $33.93. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.26 and a quick ratio of 0.99. The company has a market capitalization of $33.11 billion, a PE ratio of 26.95 and a beta of 0.76. The firm has a fifty day moving average price of $14.31 and a 200 day moving average price of $13.85.

Fresenius SE & Co. (OTCMKTS:FSNUY) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.02. Fresenius SE & Co. had a net margin of 5.26% and a return on equity of 9.72%. The firm had revenue of $6.29 billion for the quarter, compared to the consensus estimate of $6.38 billion. As a group, research analysts forecast that Fresenius SE & Co. will post 0.79 EPS for the current year.

Analysts Set New Price Targets

FSNUY has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Fresenius SE & Co. in a research note on Monday, October 27th. Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a report on Monday, December 15th. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Fresenius SE & Co. currently has a consensus rating of “Buy”.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.